EW
VYNE icon

Evoke Wealth’s VYNE Therapeutics VYNE Stock Holding History

Evoke Wealth’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9
Closed -$1.65K – 1200
2020
Q1 		$1.65K Buy
+9
New +$2.82K ﹤0.01% 836

Other funds holding VYNE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Evoke Wealth's VYNE Position: Q2 2020 in Review

Evoke Wealth sold out of VYNE Therapeutics (VYNE) in Q2 2020, closing a stake of 9 shares — an estimated $1.65K sold.

Evoke Wealth first reported a position in VYNE in Q1 2020 and held it in 1 quarter. The position peaked at $1.65K in Q1 2020. 106 funds tracked by Wall St. Rank hold VYNE as of Q2 2020.

  • Evoke Wealth reported no remaining VYNE Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Evoke Wealth sold 9 VYNE Therapeutics shares in Q2 2020, an estimated $1.65K.
  • Evoke Wealth first reported a position in VYNE Therapeutics in Q1 2020 and held it in 1 quarter.
  • Evoke Wealth's VYNE Therapeutics position peaked at $1.65K in Q1 2020.
  • 106 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q2 2020.

Based on Evoke Wealth's 13F filing for Q2 2020, filed 10 Aug 2020.